Stay updated on DTG vs EFV for HIV-TB Coinfection Clinical Trial
Sign up to get notified when there's something new on the DTG vs EFV for HIV-TB Coinfection Clinical Trial page.

Latest updates to the DTG vs EFV for HIV-TB Coinfection Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new information about the study of Dolutegravir and Efavirenz in HIV-infected patients, while significant details regarding HIV/TB co-infection and treatment interactions have been removed.SummaryDifference27%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
Stay in the know with updates to DTG vs EFV for HIV-TB Coinfection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTG vs EFV for HIV-TB Coinfection Clinical Trial page.